Literature DB >> 9792464

Regulation of the HGF-receptor c-met in the thyroid gland.

K M Schulte1, G Antoch, M Ellrichmann, M Finken-Eigen, K Köhrer, D Simon, P E Goretzki, H D Röher.   

Abstract

HGF (hepatocyte growth factor) has been characterised as an important mitogen and motogen in many epithelial cells. The biological and clinical significance of HGF and its receptor c-met in the thyroid is currently under study. Overexpression of c-met is an important feature of papillary thyroid cancer. We developed a quantitative differential RT-PCR method in order to examine HGF-receptor regulation using RNA of about 50 cells per analysis. Experiments were performed in three spontaneously transformed follicular thyroid cancer (FTC) cell lines FTC-133, 236, and 238, 7 primary cultures derived from multinodular goitres, one from Graves disease and 1 from papillary thyroid cancer (PTC). TGF-alpha and to a minor degree HGF were shown to induce a marked up-regulation of the receptor whereas bovine TSH, NaI, dbcAMP or basic FGF had no apparent effect. We conclude that expression of the HGF-receptor is under control of paracrine growth factors activating tyrosine-kinase-dependent pathways. We could demonstrate a minor stimulation of thyroid cell proliferation by HGF in presence but not in absence of 10% fetal calf serum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792464     DOI: 10.1055/s-0029-1211991

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  2 in total

1.  Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.

Authors:  M Nowak; L Siemińska; J Karpe; B Marek; B Kos-Kudła; D Kajdaniuk
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

2.  High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism.

Authors:  Decio Armanini; Davide Nacamulli; Carla Scaroni; Franco Lumachi; Riccardo Selice; Cristina Fiore; Gennaro Favia; Franco Mantero
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.